Alyeska Investment Group’s BiomX PHGE Stock Holding History

Alyeska Investment Group’s Portfolio PHGE Stock Details PHGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-22,774	Closed	-$1.45M	–	656
2024 Q2	$1.45M	Buy	+22,774	New	+$1.53M	0.01%	439

Other funds holding PHGE

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.25% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $50.6B AUM 42.84% 1-Year Est. Return

Alyeska Investment Group's PHGE Position: Q4 2025 in Review

Alyeska Investment Group sold out of BiomX (PHGE) in Q4 2025, closing a stake of 83,723 shares — an estimated $835K sold.

Alyeska Investment Group first reported a position in PHGE in Q4 2024 and held it in 3 quarters. The position peaked at $884K in Q1 2025. 11 funds tracked by Wall St. Rank hold PHGE as of Q4 2025.

Alyeska Investment Group reported no remaining BiomX position as of Q4 2025 after selling out during the quarter.
Alyeska Investment Group sold 83,723 BiomX shares in Q4 2025, an estimated $835K.
Alyeska Investment Group first reported a position in BiomX in Q4 2024 and held it in 3 quarters.
Alyeska Investment Group's BiomX position peaked at $884K in Q1 2025.
11 funds tracked by Wall St. Rank held BiomX as of Q4 2025.

Based on Alyeska Investment Group's 13F filing for Q4 2025, filed 13 Feb 2026.